Aperam (APEMY) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Aperam (OTCMKTS:APEMY) from a sell rating to a hold rating in a research note issued to investors on Tuesday.

According to Zacks, “Aperam S.A. is a manufacturer and marketer of stainless steel primarily in South America and Europe. The company produce grain oriented and non-grain oriented electrical steels and nickel alloys. Aperam S.A. is headquartered in Luxembourg. “

Separately, ValuEngine raised shares of Aperam from a hold rating to a buy rating in a report on Wednesday, January 10th.

Aperam (OTCMKTS APEMY) opened at $48.76 on Tuesday. The firm has a market cap of $4,239.59, a price-to-earnings ratio of 12.16 and a beta of 2.20. Aperam has a 1-year low of $43.50 and a 1-year high of $59.52.

Aperam (OTCMKTS:APEMY) last issued its earnings results on Tuesday, January 30th. The company reported $1.29 earnings per share for the quarter. The company had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.19 billion. Aperam had a net margin of 7.15% and a return on equity of 11.99%. equities analysts predict that Aperam will post 4.36 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This report was published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://sportsperspectives.com/2018/03/14/aperam-apemy-upgraded-at-zacks-investment-research.html.

About Aperam

Aperam produces and sells stainless and specialty steel products worldwide. It operates through three segments: Stainless & Electrical Steel, Services & Solutions, and Alloys & Specialties. The company offers steel products and electrical steels, including grain oriented, non-grain oriented, and non-grain oriented semi-processed steel products.

Get a free copy of the Zacks research report on Aperam (APEMY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Aperam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aperam and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply